Study of Efficacy of PEAR-004 in Schizophrenia
Clinical trial NCT03751280 · COMPLETED
Trial details
- NCT number
- NCT03751280
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-10
- Primary completion
- 2019-09-26
- Enrollment
- 112
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.